For: | Zhang Y, Xu YY, Chen Y, Li JN, Wang Y. Crizotinib-induced acute fatal liver failure in an Asian ALK-positive lung adenocarcinoma patient with liver metastasis: A case report. World J Clin Cases 2019; 7(9): 1080-1086 [PMID: 31123682 DOI: 10.12998/wjcc.v7.i9.1080] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v7/i9/1080.htm |
Number | Citing Articles |
1 |
Lin Guo, Tingli Tang, Dongmei Fang, Hui Gong, Bikui Zhang, Yueyin Zhou, Leiyi Zhang, Miao Yan. An Insight on the Pathways Involved in Crizotinib and Sunitinib Induced Hepatotoxicity in HepG2 Cells and Animal Model. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.749954
|
2 |
Kyle Kreitman, Satheesh P. Nair, Jiten P. Kothadia. Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature. Case Reports in Hepatology 2020; 2020: 1 doi: 10.1155/2020/8247960
|
3 |
Min Li, Zhouli Yue, Menglin Wang, Yan Wang, Peng Xiao, Wei Yuan, Jiduo Shen, Yucheng Li. Transcriptomic profiling reveals crizotinib-induced hepatotoxicity through ROS-mediated activation of the JNK/NLRP3 pathway. Toxicology Mechanisms and Methods 2025; : 1 doi: 10.1080/15376516.2025.2536058
|
4 |
Shuang Xin, Wenfeng Fang, Jianwen Li, Delan Li, Changzheng Wang, Quanfei Huang, Min Huang, Wei Zhuang, Xueding Wang, Likun Chen. Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients. Journal of Cancer Research and Clinical Oncology 2021; 147(3): 725 doi: 10.1007/s00432-020-03476-4
|